American Journal of Kidney Diseases
Volume 51, Issue 3 , Pages 395-406 , March 2008

Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD

Received 6 August 2007 ,Accepted 13 November 2007.

References 

  1. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  2. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—Measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–2483
  3. Grubb A, Nyman U, Bjork J, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the Modification of Diet in Renal Disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem. 2005;51:1420–1431
  4. Rule AD, Bergstralh EJ, Slezak JM, Bergert J, Larson TS. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int. 2006;69:399–405
  5. Filler G, Lepage N. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula?. Pediatr Nephrol. 2003;18:981–985
  6. Wright JT, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK Trial. JAMA. 2002;288:2421–2431
  7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130:461–470
  8. Lewis EJ, Kunsicker LG, Bain RP, Rohde RD Collaborative Study Group. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456–1462
  9. Klahr S, Levey A, Beck G, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease (Modification of Diet in Renal Disease Study Group). N Engl J Med. 1994;330:877–884
  10. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the MDRD and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16:763–773
  11. Israelit A, Long D, White M, Hull A. Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate. Kidney Int. 1973;4:346–349
  12. Perrone R, Steinman T, Beck G, et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: Simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. Am J Kidney Dis. 1990;26:224–235
  13. Stevens LA, Manzi J, Levey AS, et al. Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis. 2007;50:21–35
  14. Levey A, Coresh J, Greene T, et al. Expressing the MDRD Study equation for estimating GFR with standardized serum creatinine values. Clin Chem. 2007;53:766–772
  15. Newman D. Cystatin C. Ann Clin Biochem. 2002;39:89–104
  16. Kyhse-Andersen J, Schmidt C, Nordin G, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994;40:1921–1926
  17. Mosteller RD. Simplified calculation of body surface area. N Engl J Med. 1987;317:1098;(letter)
  18. Myers G, Miller W, Coresh J, et al. Recommendations for improving serum creatinine measurement: A report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem. 2006;52:5–18
  19. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  20. Dixon PM. The bootstrap and the jackknife: Describing the precision of ecological indices. In:  Scheiner SM,  Gurevitch J editor. Design and Analysis of Ecological Experiments. New York, NY: Chapman & Hall; 1993;p. 290–318
  21. Hoek F, Kemperman F, Krediet R. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18:2024–2031
  22. Sjostrom P, Tidman M, Jones I. Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest. 2005;65:111–124
  23. Larsson A, Malm J, Grubb A, Hansson L. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/min. Scand J Clin Lab Invest. 2004;64:25–30
  24. Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem. 2001;47:2055–2059
  25. Grubb AO. Cystatin C—Properties and use as diagnostic marker. Adv Clin Chem. 2000;35:63–99
  26. Knight E, Verhave J, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416–1421
  27. Manetti L, Pardini E, Genovesi M, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest. 2005;28:346–349
  28. Wasen E, Isoaho R, Mattila K, Vahlberg T, Kivela S, Irjala K. Serum cystatin C in the aged: Relationships with health status. Am J Kidney Dis. 2003;42:36–43
  29. Greene T. Effect of source population on the relationship of GFR estimates with “true GFR”. J Am Soc Nephrol. 2006;17:142A;(abstr)
  30. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–2060
  31. Shlipak M, Katz R, Sarnak M, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145:237–246
  32. Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142:497–505
  33. Fried LF, Katz R, Sarnak MJ, et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol. 2005;16:3728–3735
  34. Stevens LA, Levey AS. Chronic kidney disease in the elderly—How to assess risk?. N Engl J Med. 2005;352:2122–2124
  35. Madero M, Sarnak MJ, Stevens LA. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens. 2006;15:610–616
  36. Flodin M, Hansson L, Larsson A. Variations in assay protocol for the Dako cystatin C method may change patient results by 50% without changing the results for controls. Clin Chem Lab Med. 2006;44:1481–1485

 A list of author affiliations appears at the end of this article.Originally published online as doi:10.1053/j.ajkd.2007.11.018 on January 31, 2008.Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Marcello Tonelli, MD, University of Alberta) who served as Acting Editor-in-Chief. Details of the journal’s procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

PII: S0272-6386(07)01594-6

doi: 10.1053/j.ajkd.2007.11.018

American Journal of Kidney Diseases
Volume 51, Issue 3 , Pages 395-406 , March 2008

Article Tools

* Image Usage & Resolution